Yuan Mengfeng
Yuan Mengfeng is a renowned professor in the Department of Internal Medicine at the University of Hong Kong, specializing in liver diseases. He has been involved in research and clinical practices focused on chronic hepatitis B and its complications, such as liver cirrhosis and liver cancer. Recently, he was mentioned in the news regarding a new hepatitis B co-treatment program aimed at early detection and management of the disease, highlighting the importance of targeted screening for at-risk populations. His expertise is crucial in improving patient outcomes and reducing the incidence of severe liver conditions.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Hong Kong | 1 | 7.00 | 0.14% | +0% | 7,500,700 | 10,609 | $370,000 | 523$ |
| Totals | 1 | 7,500,700 | 10,609 | $370,000 | 523$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Hong Kong:
Yuan Mengfeng mentioned that chronic hepatitis B has no symptoms, and the median age for liver cirrhosis and liver cancer is 57 years.
7